Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...

One of the things he remembers most is the services: small, intimate gatherings of no more than 15 people, standing together united in prayer. There was no church in Aidara, a tiny, remote village in ...